☰

Nancy Benight - Publications

Affiliations: 
2012-2017 Cancer Biology University of Cincinnati, Cincinnati, OH 
Tree Info Grants Similar researchers PubMed Report error

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Hunt BG, Jones A, Lester C, Davis JC, Benight NM, Waltz SE. RON () and HGFL () Co-Overexpression Supports Breast Tumorigenesis through Autocrine and Paracrine Cellular Crosstalk. Cancers. 14. PMID 35626096 DOI: 10.3390/cancers14102493  0.708
2021 Ruiz-Torres SJ, Bourn JR, Benight NM, Hunt BG, Lester C, Waltz SE. Macrophage-mediated RON signaling supports breast cancer growth and progression through modulation of IL-35. Oncogene. PMID 34743208 DOI: 10.1038/s41388-021-02091-y  0.729
2021 Bourn JR, Ruiz-Torres SJ, Hunt BG, Benight NM, Waltz SE. Tumor cell intrinsic RON signaling suppresses innate immune responses in breast cancer through inhibition of IRAK4 signaling. Cancer Letters. 503: 75-90. PMID 33508385 DOI: 10.1016/j.canlet.2021.01.019  0.738
2017 Ruiz-Torres SJ, Benight NM, Karns RA, Lower EE, Guan JL, Waltz SE. HGFL-mediated RON signaling supports breast cancer stem cell phenotypes via activation of non-canonical β-catenin signaling. Oncotarget. 8: 58918-58933. PMID 28938607 DOI: 10.18632/Oncotarget.19441  0.833
2015 Benight NM, Wagh PK, Zinser GM, Peace BE, Stuart WD, Vasiliauskas J, Pathrose P, Starnes SL, Waltz SE. HGFL supports mammary tumorigenesis by enhancing tumor cell intrinsic survival and influencing macrophage and T-cell responses. Oncotarget. 6: 17445-61. PMID 25938541 DOI: 10.18632/Oncotarget.3641  0.664
2012 Benight NM, Waltz SE. Ron receptor tyrosine kinase signaling as a therapeutic target. Expert Opinion On Therapeutic Targets. 16: 921-31. PMID 22834780 DOI: 10.1517/14728222.2012.710200  0.639
Show low-probability matches.